Winslow Evans & Crocker’s Evolent Health EVH Stock Holding History

Winslow Evans & Crocker’s Portfolio EVH Stock Details EVH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q2	–	Sell	-58	Closed	-$2K	–	1206
2019 Q1	$2K	Buy	+58	New	+$918	﹤0.01%	1144

Other funds holding EVH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return

Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return

Bellevue Group Kuesnacht, Switzerland $4.2B AUM 54.85% 1-Year Est. Return

Aberdeen Group Edinburgh, United Kingdom $61.9B AUM 29.81% 1-Year Est. Return

ECP

Elk Creek Partners Denver, Colorado $582M AUM 10.23% 1-Year Est. Return

EAM

Eagle Asset Management St Petersburg, Florida $19.6B AUM 41.58% 1-Year Est. Return

Winslow Evans & Crocker's EVH Position: Q2 2019 in Review

Winslow Evans & Crocker sold out of Evolent Health (EVH) in Q2 2019, closing a stake of 58 shares — an estimated $2K sold.

Winslow Evans & Crocker first reported a position in EVH in Q1 2019 and held it in 1 quarter. The position peaked at $2K in Q1 2019. 183 funds tracked by Wall St. Rank hold EVH as of Q2 2019.

Winslow Evans & Crocker reported no remaining Evolent Health position as of Q2 2019 after selling out during the quarter.
Winslow Evans & Crocker sold 58 Evolent Health shares in Q2 2019, an estimated $2K.
Winslow Evans & Crocker first reported a position in Evolent Health in Q1 2019 and held it in 1 quarter.
Winslow Evans & Crocker's Evolent Health position peaked at $2K in Q1 2019.
183 funds tracked by Wall St. Rank held Evolent Health as of Q2 2019.

Based on Winslow Evans & Crocker's 13F filing for Q2 2019, filed 19 Jul 2019.